95 related articles for article (PubMed ID: 27559030)
1. Clinical and Laboratory Evaluation of a New Specific Point-of-Care Test for Intact Proinsulin.
Pfützner A; Pfützner AH; Kann PH; Burgard G
J Diabetes Sci Technol; 2017 Mar; 11(2):278-283. PubMed ID: 27559030
[TBL] [Abstract][Full Text] [Related]
2. Elevated Intact Proinsulin Levels During an Oral Glucose Challenge Indicate Progressive ß-Cell Dysfunction and May Be Predictive for Development of Type 2 Diabetes.
Pfützner A; Hermanns I; Ramljak S; Demircik F; Pfützner AH; Kann PH; Weber MM
J Diabetes Sci Technol; 2015 Sep; 9(6):1307-12. PubMed ID: 26420624
[TBL] [Abstract][Full Text] [Related]
3. Clinical and laboratory evaluation of a new specific ELISA for intact proinsulin.
Pfützner A; Pfützner AH; Kann PH; Stute R; Löbig M; Yang JW; Mistry J; Forst T
Clin Lab; 2005; 51(5-6):243-9. PubMed ID: 15991797
[TBL] [Abstract][Full Text] [Related]
4. Increased Intact Proinsulin in the Oral Glucose Challenge Sample is an Early Indicator for Future Type 2 Diabetes Development - Case Reports and Evidence from the Literature.
Pfützner A; Manessis A; Hanna MR; Lewin J
Clin Lab; 2020 May; 66(5):. PubMed ID: 32390400
[TBL] [Abstract][Full Text] [Related]
5. Clinical and laboratory evaluation of specific chemiluminescence assays for intact and total proinsulin.
Pfützner A; Kunt T; Langenfeld M; Löbig M; Knesovic M; Forst T
Clin Chem Lab Med; 2003 Sep; 41(9):1234-8. PubMed ID: 14598875
[TBL] [Abstract][Full Text] [Related]
6. Intact and total proinsulin: new aspects for diagnosis and treatment of type 2 diabetes mellitus and insulin resistance.
Pfützner A; Kann PH; Pfützner AH; Kunt T; Larbig M; Weber MM; Forst T
Clin Lab; 2004; 50(9-10):567-73. PubMed ID: 15481632
[TBL] [Abstract][Full Text] [Related]
7. Fasting intact proinsulin is a highly specific predictor of insulin resistance in type 2 diabetes.
Pfützner A; Kunt T; Hohberg C; Mondok A; Pahler S; Konrad T; Lübben G; Forst T
Diabetes Care; 2004 Mar; 27(3):682-7. PubMed ID: 14988285
[TBL] [Abstract][Full Text] [Related]
8. Immunoradiometric assay of human intact proinsulin applied to patients with type 2 diabetes, impaired glucose tolerance, and hyperandrogenism.
Chevenne D; Ruiz J; Lohmann L; Laudat A; Leblanc H; Gray IP; Passa P; Porquet D
Clin Chem; 1994 May; 40(5):754-7. PubMed ID: 8174247
[TBL] [Abstract][Full Text] [Related]
9. [Current laboratory parameters in the differential diagnosis of type 2 diabetes mellitus. Proinsulin, adiponectin and others].
Forst T; Pfützner A
Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S268-73. PubMed ID: 17139585
[TBL] [Abstract][Full Text] [Related]
10. Effect of linagliptin compared with glimepiride on postprandial glucose metabolism, islet cell function and vascular function parameters in patients with type 2 diabetes mellitus receiving ongoing metformin treatment.
Forst T; Anastassiadis E; Diessel S; Löffler A; Pfützner A
Diabetes Metab Res Rev; 2014 Oct; 30(7):582-9. PubMed ID: 24459063
[TBL] [Abstract][Full Text] [Related]
11. Both fasting and glucose-stimulated proinsulin levels predict hyperglycemia and incident type 2 diabetes: a population-based study of 9,396 Finnish men.
Vangipurapu J; Stančáková A; Kuulasmaa T; Kuusisto J; Laakso M
PLoS One; 2015; 10(4):e0124028. PubMed ID: 25853252
[TBL] [Abstract][Full Text] [Related]
12. Role of intact proinsulin in diagnosis and treatment of type 2 diabetes mellitus.
Pfützner A; Pfützner AH; Larbig M; Forst T
Diabetes Technol Ther; 2004 Jun; 6(3):405-12. PubMed ID: 15198846
[TBL] [Abstract][Full Text] [Related]
13. First direct assay for intact human proinsulin.
Houssa P; Dinesen B; Deberg M; Frank BH; Van Schravendijk C; Sodoyez-Goffaux F; Sodoyez JC
Clin Chem; 1998 Jul; 44(7):1514-9. PubMed ID: 9665431
[TBL] [Abstract][Full Text] [Related]
14. Proinsulin level in diabetes mellitus measured by a new immunochemiluminometric assay.
Wu TJ; Lin CL; Taylor RL; Kao PC
Ann Clin Lab Sci; 1995; 25(6):467-74. PubMed ID: 8572555
[TBL] [Abstract][Full Text] [Related]
15. Comparison of several point-of-care testing (POCT) glucometers with an established laboratory procedure for the diagnosis of type 2 diabetes using the discordance rate. A new statistical approach.
Püntmann I; Wosniok W; Haeckel R
Clin Chem Lab Med; 2003 Jun; 41(6):809-20. PubMed ID: 12880146
[TBL] [Abstract][Full Text] [Related]
16. IRIS II study: intact proinsulin is confirmed as a highly specific indicator for insulin resistance in a large cross-sectional study design.
Pfützner A; Standl E; Hohberg C; Konrad T; Strotmann HJ; Lübben G; Langenfeld MR; Schulze J; Forst T
Diabetes Technol Ther; 2005 Jun; 7(3):478-86. PubMed ID: 15929679
[TBL] [Abstract][Full Text] [Related]
17. Prevalence-dependent decision limits for the early detection of type 2 diabetes mellitus in venous blood, venous plasma and capillary blood during glucose challenge.
Haeckel R; Raber R; Wosniok W
Clin Chem Lab Med; 2006; 44(12):1462-71. PubMed ID: 17163824
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological PPARgamma stimulation in contrast to beta cell stimulation results in an improvement in adiponectin and proinsulin intact levels and reduces intima media thickness in patients with type 2 diabetes.
Forst T; Hohberg C; Fuellert SD; Lübben G; Konrad T; Löbig M; Weber MM; Sachara C; Gottschall V; Pfützner A
Horm Metab Res; 2005 Aug; 37(8):521-7. PubMed ID: 16138267
[TBL] [Abstract][Full Text] [Related]
19. Development of a novel immunoassay specific for mouse intact proinsulin.
Imai S; Takahashi T; Naito S; Yamauchi A; Okada C; Notsu Y; Sakikawa I; Hatanaka M; Iwasaki T; Morita A; Fujii I; Yamane S
Anal Biochem; 2015 Sep; 484():91-8. PubMed ID: 26026387
[TBL] [Abstract][Full Text] [Related]
20. Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus.
Saad MF; Kahn SE; Nelson RG; Pettitt DJ; Knowler WC; Schwartz MW; Kowalyk S; Bennett PH; Porte D
J Clin Endocrinol Metab; 1990 May; 70(5):1247-53. PubMed ID: 2186054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
